Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014
Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014
复制标题
DOI：
10.2807/1560-7917.es2014.19.42.20934
复制
发表时间：
2014-10-23
期刊：
影响因子：
19
通讯作者：
Kelly, H.
中科院分区：
文献类型：
--
作者：
Turner, N.;Pierse, N.;Kelly, H.
我们目前的流感疫苗有效性（VE）在新西兰使用的情况下测试阴性设计的初步结果2014年4月28日至8月31日。在所有年龄段中，针对因实验室确诊的流感导致的严重急性呼吸道疾病住院的年龄和住院时间调整的VE为54%（95%CI：19至74），特别是针对A（H1N1）pdm09的VE为65%（95%CI：33至81）。对于流感确诊的初级保健访视，总体VE为67%（95% CI：48至79），抗A（H1N1）pdm09的VE为73%（95% CI：50至85）。
We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test-negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54% (95% CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65% (95% CI: 33 to 81). For influenza-confirmed primary care visits, VE was 67% (95% CI: 48 to 79) overall and 73% (95% CI: 50 to 85) against A(H1N1) pdm09.